Top compounds associated with response to EML1


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 7e-05
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 8e-05
mRNA CI-1040 GDSC1000 pan-cancer AAC -0.15 9e-05
mRNA VX-11e GDSC1000 pan-cancer AAC -0.15 0.0001
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 0.0002
mRNA AZD6244 CCLE pan-cancer AAC -0.17 0.0004
mRNA temsirolimus GDSC1000 pan-cancer AAC 0.14 0.0005
mRNA RDEA119 GDSC1000 pan-cancer AAC -0.12 0.0005
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA EKB-569 GDSC1000 pan-cancer AAC -0.13 0.0006
Download CSV